{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:57:17Z","timestamp":1787317037000,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["1\/3(7)\/2020\/TMC\/R"],"award-info":[{"award-number":["1\/3(7)\/2020\/TMC\/R"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["D-II\/8823 Dt.30.07.2021"],"award-info":[{"award-number":["D-II\/8823 Dt.30.07.2021"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["1\/3(6)\/2020\/TMC\/667 R&D-II\/3805 Dt.18.03.2021"],"award-info":[{"award-number":["1\/3(6)\/2020\/TMC\/667 R&D-II\/3805 Dt.18.03.2021"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment, Research and Education in Cancer","doi-asserted-by":"publisher","award":["1\/3(4)\/2021\/TMC\/R"],"award-info":[{"award-number":["1\/3(4)\/2021\/TMC\/R"]}],"id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2025.109429","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:01:53Z","timestamp":1766793713000},"page":"109429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies"],"prefix":"10.1016","volume":"170","author":[{"given":"Rajesh Kumar","family":"Meher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeshma","family":"Kovvuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Nirmal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Kailaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Barkume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaibhaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Showkat Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kamte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2020","key":"10.1016\/j.bioorg.2025.109429_bb0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Report from National Cancer Registry Programme, India","volume":"6","author":"Mathur","year":"2020","journal-title":"JCO Glob. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109429_bb0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-022-02376-4","article-title":"Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway","volume":"41","author":"Xiao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109429_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102796","article-title":"Therapeutic potential of BAY-117082, a selective NLRP3 Inflammasome inhibitor, on metastatic evolution in human Oral squamous cell carcinoma (OSCC)","volume":"15","author":"Casili","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109429_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011108","article-title":"NLRP3 Inflammasome inhibitor BAY-117082 reduces Oral squamous cell carcinoma progression","volume":"22","author":"Scuderi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109429_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110297","article-title":"Chalcones: promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer","volume":"369","author":"WalyEldeen","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.109429_bb0045","article-title":"Recent developments in the discovery of indole-based scaffolds as promising targeted cancer therapeutics","author":"Yakkala","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109429_bb0050","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1039\/D5RA01280E","article-title":"Excavating medicinal virtues of chalcones to illuminate a new scope in cancer chemotherapy","volume":"15","author":"Nivedya","year":"2025","journal-title":"RSC Adv."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.109429_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932198","article-title":"Chalcone derivatives from Abelmoschus manihot seeds restrain NLRP3 Inflammasome assembly by inhibiting ASC oligomerization","volume":"13","author":"Su","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109429_bb0065","article-title":"Chalcone: a potential scaffold for NLRP3 inflammasome inhibitors","volume":"7","author":"Thapa","year":"2023","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109429_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23074001","article-title":"A review of the recent developments of molecular hybrids targeting tubulin polymerization","volume":"23","author":"Ebenezer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109429_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051587","article-title":"Indole-based tubulin inhibitors: binding modes and SARs investigations","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109429_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109429_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209420","article-title":"Deciphering the ATP-binding mechanism(s) in NLRP-NACHT 3D models using structural bioinformatics approaches","volume":"13","author":"Maharana","year":"2018","journal-title":"PloS One"},{"issue":"7761","key":"10.1016\/j.bioorg.2025.109429_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seminoncol.2025.152337","article-title":"The critical role of NLRP3 in drug resistance of cancers: focus on the molecular mechanisms and possible therapeutics","volume":"52","author":"Kuriakose","year":"2025","journal-title":"Semin. Oncol."},{"issue":"7717","key":"10.1016\/j.bioorg.2025.109429_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15430\/JCP.2017.22.2.62","article-title":"Inflammasome as a therapeutic target for Cancer prevention and treatment","volume":"22","author":"Thi","year":"2017","journal-title":"J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0300891619868007","article-title":"Insights into inflammasome and its research advances in cancer","volume":"105","author":"Cao","year":"2019","journal-title":"Tumori"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109429_bb0115","first-page":"3424","article-title":"HIF-1alpha promotes NLRP3 inflammasome activation in bleomycin-induced acute lung injury","volume":"20","author":"Huang","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109429_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"issue":"7081","key":"10.1016\/j.bioorg.2025.109429_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.bioorg.2025.109429_bb0130","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"LoDoCo2 trial, colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109429_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104447","article-title":"Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors","volume":"105","author":"Kode","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109429_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of Inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0145","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acsomega.2c07138","article-title":"6-Shogaol exhibits anti-viral and anti-inflammatory activity in COVID-19-associated inflammation by regulating NLRP3 Inflammasomes","volume":"8","author":"Kode","year":"2023","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109429_bb0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109429_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"7904","key":"10.1016\/j.bioorg.2025.109429_bb0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109429_bb0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1074-7613(01)00229-1","article-title":"Rapid secretion of interleukin-1beta by microvesicle shedding","volume":"15","author":"MacKenzie","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2025.109429_bb0175","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.2147\/JIR.S512770","article-title":"The role of NLRP3 Inflammasome in Oral squamous cell carcinoma","volume":"18","author":"Shi","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109429_bb0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-018-02865-1","article-title":"Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells","volume":"9","author":"Seo","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109429_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16183226","article-title":"The solute carrier (SLC) transporter superfamily as therapeutic targets for the treatment of head and neck squamous cell carcinoma","volume":"16","author":"Cho","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0205","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12885-018-4403-9","article-title":"NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109429_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109429_bb0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fnagi.2018.00116","article-title":"The NLRP3-caspase 1 Inflammasome negatively regulates autophagy via TLR4-TRIF in prion peptide-infected microglia","volume":"10","author":"Lai","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0225","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109429_bb0230","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 Inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23030522","article-title":"Inhibiting the NLRP3 Inflammasome activation with MCC950 ameliorates diabetic encephalopathy in db\/db mice","volume":"23","author":"Zhai","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0240","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109429_bb0245","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11929","article-title":"ASC filament formation serves as a signal amplification mechanism for inflammasomes","volume":"7","author":"Dick","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2025.109429_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molimm.2018.09.010","article-title":"The role of mitochondria in NLRP3 inflammasome activation","volume":"103","author":"Liu","year":"2018","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial Cardiolipin is required for Nlrp3 Inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0270","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0275","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","article-title":"Mitochondria in the regulation of innate and adaptive immunity","volume":"42","author":"Weinberg","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109429_bb0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molmed.2014.11.008","article-title":"Mitochondria: diversity in the regulation of the NLRP3 inflammasome","volume":"21","author":"Gurung","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109429_bb0285","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","article-title":"Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation","volume":"286","author":"Harris","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109429_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.bioorg.2025.109429_bb0300","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"Web Server issue","key":"10.1016\/j.bioorg.2025.109429_bb0305","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109429_bb0310","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109429_bb0315","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.109429_bb0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"Softwarex"},{"issue":"25","key":"10.1016\/j.bioorg.2025.109429_bb0325","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109429_bb0330","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109429_bb0335","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109429_bb0340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01612674","article-title":"Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors","volume":"116","author":"Tatake","year":"1990","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:09:55Z","timestamp":1770066595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825013094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":68,"alternative-id":["S0045206825013094"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109429","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109429"}}